Skip to Navigation

Neocate Infant je směs esenciálních a neesenciálních aminokyselin, sacharidů, tuků, minerálních látek, stopových prvků a vitaminů, s přídavkem LCP (DHA a ARA) a nukleotidů pro kojence do 12 měsíců.

Neocate Infant  je výživa na bázi 100% volných aminokyselin, tedy hypoalergenní formule, která prokazatelně a rychle uleví od příznaků ABKM bez ohledu na jejich závažnost do 3-14 dní.16,17 Je navržen speciálně pro nutriční potřeby kojenců s alergií na bílkovinu kravského mléka a vícenásobnou intolerancí bílkovin v potravinách.

 

Reference:

1. Gill BD, Indyk HE. Determination of Nucleotides and Nucleosides in Milks and Pediatric Formulas: A Review. Journal of AOAC International. 2007;90(5):1354-1364. 2. Sanchez CL, Cubero J, Sanchez J, et al. The possible role of human milk nucleotides as sleep inducers. Nutritional Neuroscience. 2009;12(1):2-8. 3. Barrio J, Diaz-Martin JJ, Manrique I. Expert consensus on the nutritional aspects of initial and follow-on infant formulas. An Pediatr (Barc). 2015;83(6):376-386. 4. Adamkin DH. Controversies in neonatal nutrition: docosahexanoic acid (DHA) and nucleotides. Journal of Perinatology. 2007;27:S79-S82. 5. Hess JR, Greenberg NA. The Role of Nucleosides in the Immune and Gastrointestinal Systems: Potential Clinical Applications. Nutrition in Clinical Practice. 2012;27(2):281-294. 6. Maldonado J, Navarro J, Narbona E, et al. The influence of dietary nucleotides on humoral and cell immunity in the neonate and lactating infant. Early Human Development. 2001;65:S69-S74. 7. Leach JL, Baxter JH, Molitor BE, et al. Total potentially available nucleosides of human milk by stage oflactation. Am J Clin Nutr. 1995;61:1224-1230. 8. EFSA, Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development pursuant to Article 14 of Regulation (EC) No 1924/2006. The EFSA Journal, 2009. 941: 1-14. 9. Foiles AM, Kerling EH, Wick JA, et al. Formula with long-chain polyunsaturated fatty acids reduces incidence of allergy in early childhood. Pediatr Allergy Immunol. 2016 Mar;27(2):156-61. 10. Qawasmi A, Landeros- Weisenberger A, Bloch MH. Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics. 2013 Jan;131(1):e262-72. 11. Koletzko A, Niggemann B, Arato A. Diagnostic Approach and Management of Cow´s-Milk Protein Allergy in Infants and Children: ESPGHAN GI Committee Practical Guiedelines. JPGN. 2012;55:221-229. 12. Venter C, Brown T, Shah N, et al. Diagnosis and management of non-IgE-mediated cow ’ s milk allergy in infancy - a UK primary care practical guide. Clin Transl Allergy. 2013 Jul 8;3(1):23. 13. Ludman S, Shah N, Fox AT. Managing cows’ milk allergy in children. BMJ. 2013 Sep 16;347:f5424. 14. Kaczmarski M, Żur E, Kondej- Muszyńska K. Therapeutic and nutritional applications of amino acid-based elemental formulas in children with food allergies: a preliminary report. Post Dermatol Alergol. 2012;24(2):86–93. 15. Vandenplas Y, Brueton M, Dupont Ch. Guidelines for the diagnosis and management of cow´s milk protein allergy in infants. Arch Dis Child. 2007;92:902-908. 16. de Bossieu, Matarazzo P, Dupont C. Allergy to extensively hydrolyzed cow milk proteins in infants: identification and treatment with an amino acid-based formula. J Pediatr. 1997 Nov;131(5):744-7. 17. Vanderhoof JA, Murray ND, Kaufman SS, et al. Intolerance to protein hydrolysate infant formulas: an underrecognized cause of gastrointestinal symptoms ininfants. J Pediatr. 1997Nov;131(5):741-4. 18. Ashworth A, Khanum S, Jackson A, et al. Guidelines for the inpatient treatment of severely malnourished children. WHO. 2003. ISBN 92 4 154609 3. 19. Report of a Joint WHO/FAO/ UNU Expert Consultation (2007). Protein and Amino Acid Requirements in Human Nutrition. WHO Technical Report Series No. 935. World Health Organization: Geneva.